KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Cost and cost-effectiveness of attractive targeted sugar baits (ATSB) in the context of a phase III cluster randomized control trial in Western Province, Zambia.

Brooke Mancuso, Erica Orange, Thomas P Eisele, Ruth A Ashton, Megan Littrell, Mulenga Matches, John M Miller, Javan Chanda, Sosenna Assefa, Joseph Wagman, Kafula Silumbe, Busiku Hamainza, Kochelani Saili, Laurence Slutsker, Joshua Yukich

Malar J 25(1) 54

PMID41420162
PMCIDPMC12831337
DOI10.1186/s12936-025-05716-9
发表日期2025-12-19
入排依据:未发现恶性肿瘤人群证据。
已检查 5 张 PubMed Figure,均未识别为 KM 图:Fig. 1:AI 判定为 other;Fig. 2:AI 判定为 other;Fig. 3:AI 判定为 other;Fig. 4:AI 判定为 other;Fig. 5:AI 判定为 other。
摘要

摘要

BACKGROUND: Vector control is the most important malaria prevention strategy in Zambia. Attractive Targeted Sugar Baits (ATSB) are a potential new tool for vector control in this setting, which, if efficacious, would be intended to supplement insecticide-treated bed nets (ITNs) and indoor residual spraying (IRS). ATSBs target and kill sugar feeding mosquitoes, potentially limiting the spread of malaria. No information on the cost or cost-effectiveness of deployment of ATSB stations is currently available. METHODS: A cluster randomized control trial (cRCT) was carried out in Western Province, Zambia to assess the efficacy of Sarabi v.1.2 ATSB stations in a highly malarious setting. Costs associated with the procurement, distribution, maintenance, and disposal of the ATSB stations were collected over a two-year period. These costs were assessed alongside the main trial efficacy outcomes to determine cost-effectiveness and potential budget impact on the deployment of ATSB stations in this setting. Total costs, incremental costs, incremental cost-effectiveness ratios (ICER) and budget impact were estimated using trial data. One-way, scenario and probabilistic sensitivity analysis were performed to further determine the impact of assumptions and uncertainty on cost-effectiveness estimates, and the potential cost implications of alternative deployment scenarios. Sub-group analysis was performed to determine the impact of deployment in settings with the most favorable effect scenarios. RESULTS: The total cost of the intervention in the context of the cRCT was USD 1,261,515. ATSB cost accounted for 46% of the total cost followed by personnel (25%), supplies and transport (13% each), equipment (2%) and storage (1%). Over the two year (14-month intervention) this resulted in an estimated ICER of USD 79 per malaria incident case averted or USD 919 per disability-adjusted life year (DALY) averted and USD 10.08 per person-year protected. In a subset of high-density ATSB clusters ICER was USD 42 per incident case averted and USD 493 per DALY averted and USD 4.35 per person-year protected. Probabilistic sensitivity analysis indicated that deployment in areas with higher structure density may be more cost-effective, especially if potential cost-savings are considered. However, effect estimates in this subgroup were highly uncertain and not statistically significant. While the scenario appeared more cost-effective than the base case on the cost-effectiveness acceptability curve (CEAC), the probability of cost-effectiveness reached only around 70%, falling short of the commonly used 80% threshold and remaining relatively weak. CONCLUSIONS: ATSB Sarabi v.1.2 as deployed in western Zambia were not likely to be cost -effective. ATSB would need to demonstrate higher or more certain efficacy along with affordable alternative distribution strategies prior to any deployment at scale. Trial registration The trial is registered on clinicaltrials.gov under registration number: NCT04800055.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(5,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Fig. 1Fig. 1 Total and proportional costs of ATSB by intervention phase and line-item category
非 KM Figure
Fig. 2Fig. 2 ICER Sensitivity to IRR (in USD per DALY averted): This curve illustrates the relationship between the incidence rate ratio (IRR) and the incremental cost-effectiveness ratio (ICER), expressed in USD per DALY averted. The analysis shows how the ICER increases as the IRR approaches 1, indicating reduced intervention effectiveness. The red dashed line represents the cost-effectiveness threshold of 0.5 × GDP per capita (USD 729). Values below this line are considered cost-effective under this benchmark under certain standards [42]
非 KM Figure
Fig. 3Fig. 3 Cost-effectiveness acceptability curves: Each curve is based on 10,000 probabilistic iterations, reflecting uncertainty in both costs and effects. The curves show the probability that each scenario is cost-effective across a range of willingness-to-pay thresholds per DALY
非 KM Figure
Fig. 4Fig. 4 Cluster Level Costs per Outcome: This figure displays the distribution of ATSB intervention costs across clusters in 2023 USD for the base case scenario, presented as cost per ATSB, per household (HH), per person, and per structure. Violin plots illustrate the variability in cluster-level costs, with median values and interquartile ranges overlaid. Costs per household exhibited the greatest variation across clusters, while costs per ATSB were the most consistent
非 KM Figure
Fig. 5Fig. 5 Data Cloud Various Costing Scenarios for ATSB: Each data cloud represents the distribution of results from 10,000 probabilistic iterations for the corresponding scenario. These simulations incorporate parameter uncertainty to reflect variability in cost-effectiveness outcomes
非 KM Figure